Production (Stage)
E
Oaktree Acquisition Corp. III Life Sciences OACC
$10.52 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2024
Total Cash And Short-Term Investments --
Total Receivables --
Inventory --
Prepaid Expenses --
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets --

Total Current Assets --
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 558.76%
Total Assets 558.76%

Total Accounts Payable --
Total Accrued Expenses -60.34%
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 657.92%
Total Other Current Liabilities 657.92%
Total Current Liabilities 640.60%

Total Current Liabilities 640.60%
Long-Term Debt --
Short-term Debt --
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 640.60%

Common Stock & APIC 0.00%
Retained Earnings -176.44%
Treasury Stock & Other --
Total Common Equity -403.95%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible --
Preferred Stock, Others --
Total Preferred Equity --

Total Common Equity -403.95%
Total Preferred Equity --
Total Minority Interest --
Total Equity -403.95%